Related Experiment Video
Updated: May 15, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Construction of a circRNA-miRNA-mRNA Regulatory Network for the Immune Regulation of Lung Adenocarcinoma
Hanyi Li1,2, Xin Jin1,2, Wei Li1,2
1Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Background:
Recent research has highlighted the significance of circular RNAs (circRNAs) as pivotal regulators in the progression of tumors and the therapeutic response in non-small cell lung cancer (NSCLC). These circRNAs function through a sponge mechanism, interacting with microRNAs (miRNAs) to modulate mRNA expression levels. Nevertheless, the precise role of the circRNA-miRNA-mRNA regulatory network in immune regulation within lung adenocarcinoma (LUAD) remains inadequately understood.
Methods And Materials:
We utilized microarray datasets from the GEO NCBI database (GSE101586) to identify differentially expressed circRNAs (DEcircRNAs) in LUAD. CircBank was employed to predict the target miRNAs of DEcircRNAs, which were subsequently intersected with miRNAs from the GSE36681 database. The identified miRNAs were then predicted to target mRNAs using miRDB and miWalk, and intersections with immune-related genes from the IMMPORT database were analyzed. Protein-protein interaction (PPI) networks were constructed using Cytoscape software. The DAVID functional annotation tool was utilized to explore potential biological processes, molecular functions, and KEGG pathways associated with LUAD. Gene expression and Kaplan-Meier survival analyses were conducted to establish a key regulatory network and to assess immune cell infiltration and Pearson correlation for significant target genes. Finally, we selected the most significantly upregulated circRNA with differential expression for validation through in vitro experiments.
Results:
Our analysis identified a total of 7 upregulated and 42 downregulated circRNAs, along with 10 significant miRNAs and 20 target mRNAs. KEGG enrichment analysis indicated that these components are primarily enriched in the ErbB signaling pathway. Furthermore, Gene Ontology (GO) analysis revealed significant enrichment in responses to organic substances, cytokine-mediated signaling pathways, cellular responses to cytokines, responses to chemical stimuli, steroid hormone receptor activity, ErbB-3 class receptor binding, oxysterol binding, signal receptor activity, and molecular transducer activity. Notable core mRNAs identified included OAS1, VIPR1, and PIK3R1. Subsequently, we constructed a regulatory network comprising 6 DEcircRNAs, 3 DEmiRNAs, and 3 DEmRNAs. Through ssGSEA and CIBERSORT analyses, we observed significant differences in immune cell infiltration levels between the NSCLC cohort and the control group. Knocking down the expression of hsa_circ_0079557 significantly inhibited the viability, proliferation, migration, and invasion of LUAD cells.
Conclusion:
We have established a circRNA-miRNA-mRNA regulatory network that offers novel insights into the molecular mechanisms governing immune regulation in LUAD. Future research should aim to translate these findings into clinical applications to enhance patient outcomes.
Insights
Circular RNAs (circRNAs) regulate non-small cell lung cancer (NSCLC) progression and immune responses. This study identified a novel circRNA-miRNA-mRNA network in lung adenocarcinoma (LUAD), with hsa_circ_0079557 knockdown inhibiting LUAD cell growth.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Circular RNAs (circRNAs) are key regulators in tumor progression and therapy response in non-small cell lung cancer (NSCLC).
- circRNAs modulate mRNA expression via microRNA (miRNA) sponging.
- The circRNA-miRNA-mRNA network's role in lung adenocarcinoma (LUAD) immune regulation is unclear.
Purpose of the Study:
- To elucidate the circRNA-miRNA-mRNA regulatory network in LUAD immune responses.
- To identify key molecular players and pathways involved in LUAD immune regulation.
Main Methods:
- Microarray data (GSE101586) identified differentially expressed circRNAs (DEcircRNAs) in LUAD.
- circRNA-miRNA-mRNA interactions were predicted and intersected with immune genes (IMMPORT).
- Protein-protein interaction networks, functional enrichment (DAVID), and immune cell infiltration analyses (ssGSEA, CIBERSORT) were performed. In vitro experiments validated a key circRNA.
Main Results:
- Identified 7 upregulated and 42 downregulated circRNAs, 10 miRNAs, and 20 target mRNAs.
- Enrichment analysis highlighted the ErbB signaling pathway and immune-related functions (cytokine signaling).
- A regulatory network of 6 DEcircRNAs, 3 DEmiRNAs, and 3 DEmRNAs was constructed. Knockdown of hsa_circ_0079557 inhibited LUAD cell proliferation and invasion, with altered immune cell infiltration observed.
Conclusions:
- Established a novel circRNA-miRNA-mRNA network providing insights into LUAD immune regulation.
- Findings offer potential therapeutic targets for LUAD treatment.
- Further research is needed to translate these discoveries into clinical applications for improved patient outcomes.
Related Concept Videos
MicroRNAs
lncRNA - Long Non-coding RNAs
Experimental RNAi

